# Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression

Study · id `cardio:ct-nct04511468` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04511468](<https://clinicaltrials.gov/study/NCT04511468>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT04511468

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 670 participants.

## Technical summary

Registry record NCT04511468. Randomized; quadruple masking; primary purpose prevention. Start 2021-06-23 (actual); primary completion 2024-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 2
- Enrolled: 670 participants (planned count; ClinicalTrials.gov record NCT04511468, source copy `cardio:ctgov-nct04511468-2024-11-05`, retrieved 2026-11-18)
- Started: 2021-06-23 (actual) (ClinicalTrials.gov record NCT04511468, source copy `cardio:ctgov-nct04511468-2024-11-05`, retrieved 2026-11-18)
- Primary completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT04511468, source copy `cardio:ctgov-nct04511468-2024-11-05`, retrieved 2026-11-18)
- Completion: 2025-03-31 (anticipated) (ClinicalTrials.gov record NCT04511468, source copy `cardio:ctgov-nct04511468-2024-11-05`, retrieved 2026-11-18)
- Countries: Indonesia (ClinicalTrials.gov record NCT04511468, source copy `cardio:ctgov-nct04511468-2024-11-05`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04511468-2024-11-05`, retrieved 2026-11-18)

## The registry's words

- Brief title: Zinc, Chromium, Vitamin C, and Copper Combination Supplement for Prediabetes Progression
- Acronym: CHANGE
- Condition: PreDiabetes
- Condition: Nutrition
- Intervention (Dietary supplement): Zinc, Chromium, Vitamin C, and Copper Supplementation
- Intervention (Behavioral): Standard healthy lifestyle intervention
- Intervention (Other): Placebo
- Lead sponsor: Universitas Indonesia
- Lead sponsor class: OTHER
- Collaborator: Blackmores Institute
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Prediabetes (`cardio:prediabetes`)
- Registry lists this organization as the lead sponsor: Universitas Indonesia (`cardio:org-universitas-indonesia`)

## Provenance

Content hash: 245d82dcd3ef87c221176bfa2d9a48b461106367cb858f9d9c193b8ef1d5c9da
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
